MODASA Pharmaceuticals

What MODASA Pharmaceuticals does

MODASA Pharmaceuticals Pvt. Ltd. is an India-based, privately held B2B manufacturer and supplier of pharmaceutical ingredients, intermediates, and finished formulations. Founded in September 2008 as a partnership firm and restructured into a private limited company under the Companies Act 1956 in April 2011 (registration U51397GJ2011PTC065202), the company operates from a registered office and manufacturing facility in Modasa, Sabarkantha district, Gujarat, with a sales/contact office in Ahmedabad Naroda. It organizes its offering into six product categories — Active Pharmaceutical Ingredients (APIs), Veterinary APIs, Excipients & Fine Chemicals, API Intermediates, Agro Chemicals, and Pharmaceutical Formulations (including Benfotiamine and Bupropion HCl) — and sells under the MODASA brand.

The company's technology backbone is a chemical-process manufacturing platform: teams apply the latest reaction technologies under stringent process parameters to produce APIs and intermediates using novel, non-infringing routes, supported by strict GMP compliance and integrated manufacturing that the company states yields significant cost savings. Core technical claims center on proprietary process technology, non-infringement of incumbent patents, and One Star Export House / ISO / GMP credentials that enable cross-border pharmaceutical supply. There is no disclosed AI/ML capability, no patents or trademarks list, and no published research footprint.

Commercially, MODASA runs a sales-led, quote-based B2B model with multi-year contracts, domestic India distribution, and direct exports to 22+ countries spanning South America, Oceania, Europe, Eastern Europe, Africa, the Middle East, South Asia, Southeast Asia, and East Asia. GTM combines direct inquiry/quote funnels, email marketing, and a strategic business-partner network that provides market analysis and commercial assessments. Pricing is fully custom and not publicly disclosed; no anchor customer logos, revenue figures, funding history, or institutional investors are present in the record. The company is not a subsidiary and has no disclosed M&A activity.

Name

MODASA Pharmaceuticals

Legal name

MODASA Pharmaceuticals Pvt. Ltd.

Website

https://modasa.co.in

Company type

Private

Founded year

2008

Operating status

Operating

Headcount range

11–50 employees

Short description

MODASA Pharmaceuticals is an India-based B2B manufacturer and supplier of Active Pharmaceutical Ingredients, API intermediates, veterinary APIs, excipients, fine chemicals, agro chemicals, and pharmaceutical formulations, serving pharmaceutical companies across India and 22+ export markets.

Ownership category

akta.pro rank

Product category

Pharmaceutical Ingredients Manufacturing

NAICS

Pharmaceutical Preparation Manufacturing (325412), All Other Chemical Product and Preparation Manufacturing (32599)

SIC

Medicinal Chemicals & Botanical Products (2833), Wholesale-Chemicals & Allied Products (5160)

akta.pro industry

PRIMARYHLAGAHAB

Small-Molecule API Commercial Manufacturing

Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/API & Small-Molecule Development/Manufacturing Services

SECONDARYHLAIABAG

Generic APIs & Intermediates (Active Ingredients)

Healthcare & Life Sciences/Pharmaceuticals/Generic Pharmaceuticals

SECONDARYHLAIAJAO

Compounding Ingredient & API Distributors (Pharma Supply)

Healthcare & Life Sciences/Pharmaceuticals/Pharmaceutical Distribution & Wholesaling

SECONDARYHLAGAHAM

Small-Molecule CMC Documentation & Regulatory Support (DMF/CMC)

Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/API & Small-Molecule Development/Manufacturing Services

Keywords

• Pharmaceutical manufacturing
• Active pharmaceutical ingredients
• API intermediates
• Veterinary APIs
• Pharmaceutical excipients

Headquarters

HQ city

Ahmedabad

HQ country

India

HQ region

Asia

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

1. Bulk Drugs and Pharmaceutical Ingredients: Manufacturing and supplying bulk drugs, pharmaceutical ingredients, and speciality chemicals to Indian and overseas customers
2. API Intermediates: Production and sale of active pharmaceutical ingredient intermediates
3. Veterinary APIs: Specialised APIs for veterinary pharmaceutical applications
4. Excipients and Fine Chemicals: Supply of pharmaceutical excipients and fine chemicals
5. Pharmaceutical Formulations: Finished pharmaceutical formulations including Benfotiamine and Bupropion HCl
6. Agro Chemicals: Agrochemical products for agricultural applications

Pricing tiers

Go-to-market motion2 records

Distribution channels2 records

Marketing channels3 records

Core offering

MODASA Pharmaceuticals manufactures and supplies Active Pharmaceutical Ingredients (APIs), API intermediates, veterinary APIs, pharmaceutical excipients, fine chemicals, agro chemicals, and finished pharmaceutical formulations to Indian and overseas customers. Operating as a B2B contract manufacturer under the MODASA brand, the company leverages proprietary non-infringing technologies and fully integrated manufacturing processes to deliver quality products at reasonable prices, exporting to customers in 22+ countries.

Product overview

MODASA Pharmaceuticals operates as a B2B pharmaceutical manufacturer and supplier offering a diversified portfolio organized into six product categories: Active Pharmaceutical Ingredients (APIs), Veterinary APIs, Excipients & Fine Chemicals, API Intermediates, Agro Chemicals, and Pharmaceutical Formulations. The company supplies bulk drugs, pharmaceutical ingredients, and speciality chemicals to customers in India and overseas markets under the MODASA brand, positioning itself as a single-source provider that consolidates multiple product lines to serve customers from one point.

Differentiator

Problem solved

Functional benefit

Products and services

• Active Pharmaceutical Ingredients (APIs) Core pharmaceutical active ingredients manufactured and supplied for human drug formulation, including Clotrimazole, Cetirizine DiHCl, Clopidogrel Bisulphate, Calcium ketoanalogues (Leucine, Isoleucine, Valine, Phenylalanine salts), Calcium-Dl-2Hydroxy-4(Methylthio) Butyrate, Divalproex Sodium, Ferric Carboxymaltose, Levocetirizine DiHCl, Sodium Valproate, and Valproic Acid. Targeted at Indian and overseas pharmaceutical formulation companies.
• Veterinary APIs Active pharmaceutical ingredients specifically formulated and supplied for veterinary applications, including Riboflavin 5 Phosphate Sodium, for animal-health drug manufacturers.
• Excipients & Fine Chemicals Pharmaceutical excipients and fine chemicals supplied as inactive ingredients used in drug formulations, for pharmaceutical manufacturers.
• API Intermediates Intermediate compounds manufactured for use in the synthesis of active pharmaceutical ingredients during drug substance production, supplied to API manufacturers.
• Agro Chemicals Chemical products developed for agricultural applications, supplied to agrochemical companies.
• Pharmaceutical Formulations Finished pharmaceutical dosage forms supplied under the MODASA brand, including Benfotiamine and Bupropion HCl products, for distributors and pharmaceutical companies.

Quantifiable outcome

• One-stop solution for pharmaceutical ingredients

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

One partnership is on record.

• Strategic Business Partners (Unnamed)coreStrategic or Co-development PartnerMODASA maintains strategic business partnerships with customers and suppliers who are strategically important to the company's growth. Partners perform in-depth analysis of market conditions and current trends to identify market potential and growth opportunities. They provide strategic recommendations and commercial assessments for business development.

Scale indicators3 records

Recent moves7 records

Expansion highlights5 records

Direct peers

• Aarti Drugs: Indian API manufacturer supplying a broad portfolio of APIs, intermediates, and specialty chemicals to global pharma customers. Direct overlap with MODASA's APIs and intermediates product lines and similar B2B export-led model.
• Granules India: Indian manufacturer of APIs, pharmaceutical formulations intermediates, and finished dosages. Closely comparable to MODASA on the intermediates-to-formulation value chain and on export-led B2B customer base.
• Suven Pharmaceuticals: India-based API and intermediates CDMO serving global pharma customers. Closely aligned with MODASA's API/intermediates product focus and B2B export-driven business model.
• Symbiotec Pharmalab: Indian API manufacturer focused on steroids and hormone APIs. Comparable in size band, export orientation, and B2B API/intermediates business, though narrower in therapeutic area.

Broad incumbents

• Jubilant Pharmova: Indian pharma and API player with international API and CDMO operations. Comparable on small-molecule API manufacturing and global export reach, with broader scale and a more diversified service offering.
• Laurus Labs: Indian-headquartered API and formulation manufacturer with multi-continent export reach. Overlaps with MODASA on API manufacturing, intermediates, and finished formulations, including specialty molecules.
• Aurobindo Pharma: Vertically integrated Indian pharma company with one of the largest API manufacturing footprints in India. Comparable product mix (APIs and formulations) and global B2B distribution model, though at vastly greater scale.
• Divis Laboratories: Large Indian API and intermediates manufacturer with global export presence. Comparable in product category (small-molecule APIs and intermediates) and customer base, but operates at materially larger scale and broader regulatory footprint.
• Piramal Pharma Solutions: India-headquartered API and contract development/manufacturing business with global customers. Overlaps with MODASA on API manufacturing, regulatory documentation, and export-led B2B sales.
• Hetero Labs: Vertically integrated Indian API and formulations manufacturer with a large global export footprint. Overlaps with MODASA on APIs, intermediates, and finished formulations.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about MODASA Pharmaceuticals